Rahmi Oklu MD, PhD retweeted
Happy 10 years at Mayo @rahmioklu ! 🎉 Your creativity and innovation keep inspiring all of us every day. 👏
Rahmi Oklu MD, PhD retweeted
Inspiring
@rahmioklu
@VKumbhari
Thank you for being our Deans speaker
@MayoClinic
@MayoClinicNeuro
@DoctorQMDLab
Thank you Dr Oklu for all you do for science and humanity
Thank you Dr Kumbhari for hosting Dr Oklu
Our work on next-gen chemoembolization is the cover article in Advanced Materials! With this approach, we show instant non-radioactive segmental embolization, uniform delivery of large therapeutics ie, Nivolumab, and targeted segmental/tumor ablation using the portal veins.
Rahmi Oklu MD, PhD retweeted
An injectable ionic liquid can safely ablate prostate tissue in large and small animals while delivering anticancer drugs to suppress tumor cells, supporting its utility as a safer therapy for #BenignProstateHyperplasia. @rahmioklu @MayoClinic scim.ag/7zs
Just published! Great work to entire team! Prostate ablation for LUTS from BPH and prostate cancer! Direct needle injection into prostate for ablation takes min to do-no pain, no bleeding, no nerve injury, no incontinence! Phase2 trials very soon! @SIRspecialists @MayoClinic
Rahmi Oklu MD, PhD retweeted
Our @MayoClinicAZ_IR Faculty Dr. @rahmioklu will review in live cases how to use #Obsidio and how not to use Obsidio.
Rahmi Oklu MD, PhD retweeted
Ready to learn more about #Obsidio #ConformableEmbolic? Join us July 27th for an in-person masterclass with expert faculty Kevin Henseler, MD, FACR and Rahmi Oklu, MD, PhD @rahmioklu. Spots are limited - secure yours soon! Register here: bit.ly/45EpCsP
From IR lab @MayoClinicAZ_IR, Congrats to post-doc Dr. Enes Cevik for this outstanding work! PVE, segmental ablation, drug delivery using a novel liquid embolic formulation. Phase 1 data was recently presented at SIR2024. @kocuniversity @vkv_amerikan
doi.org/10.1002/adma.2024025…
Rahmi Oklu MD, PhD retweeted
At SIR #OBSIDIO #ConformableEmbolic completes LME demonstrating real-world technical success in a wide range of clinical applications including trauma which constituted roughly 1/3 of applications (45/131). Learn more about Obsidio: bit.ly/3PAwjFx bit.ly/3wnXYCT
Rahmi Oklu MD, PhD retweeted
ACS Nano Editors at Fellow Induction Ceremony at AIMBE (American Institute for Medical and Biological Engineering) @aimbe @acsnano @thedeanh @NatalieArtzi @Tony_Y_Hu @rahmioklu and Bozhi Tian – at Central Region, Singapore
Finally the day has come! Tuesday 9:55 AM in the Corporate Expo Theater at the Society of Interventional Radiology Meeting, Salt Lake City, Utah, clinical data on the Next Gen BPH and Liver Tumor Treatment will be presented. Stop by our expo booth #1331 #sir2024




























